Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
If youre curious about whether you qualify for semaglutides like Ozempic, talk to your doctor
Retatrutide is an investigational peptide compound that acts as a triple agonist, targeting three hormone receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Retatrutide does not hold MHRA marketing authorisation and is not licensed for use in the UK outside of regulated clinical trials
220-22, Okobi, Okelue E., et al
Q: Who is Foundayo FDA-approved for
US$ 21.06
US$ 27.27
US$ 24.39
